Proto Labs Inc
PRLB
Get informed when a big investor buys or sells
+ FollowCurrent Fair Value
61.2% downsideOvervalued by 61.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $1.80 Billion |
|---|---|
| Enterprise Value | $1.68 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.89 |
| Beta | 1.37 |
| Outstanding Shares | 23,835,612 |
Return
| Return on Equity | 3.77% |
|---|---|
| Return on Assets | 3.31% |
| Return on Invested Capital | 4.30% |
Valuation & Multiples
| P/E Ratio | 70.12 |
|---|---|
| PEG | 55.93 |
| Price to Sales | 3.4 |
| Price to Book Ratio | 2.67 |
| Enterprise Value to Revenue | 3.08 |
| Enterprise Value to EBIT | 55.27 |
| Enterprise Value to Net Income | 65 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Next Earnings Call
Institutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 15.81% |
|---|---|
| Total Calls | 140,000▲ 225.58% |
| Total Puts | -▼ 100.00% |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 92.88%▲ 0.48% |
|---|---|
| Total Invested | $1.26B▼ 5.76% |
| Investors Holding | 264▲ 24.00% |
ESG Score
No data
About Proto Labs Inc
2,700 employees
CEO: Victoria Holt Protolabs is a company that provides rapid manufacturing of low-volume 3D printed, CNC-machined, sheet metal, and injection-molded custom parts for prototyping and short-run production. Markets like medical devices, electronics, applianc...
Relevant Senate Committees
As the primary committee for taxation and trade, it directly impacts Protolabs' corporate tax burden, international trade operations (supply chain, global sales), and the economic health of key customer industries.
This committee directly allocates federal spending across various sectors, including defense, scientific research, and infrastructure, all of which are potential sources of demand or funding for Protolabs' services.
Regulations from the FDA (critical for medical device clients) and labor laws (impacting Protolabs' manufacturing workforce costs) fall under this committee's direct jurisdiction.
The committee's oversight of intellectual property law is crucial for Protolabs' business protecting client designs, and its antitrust jurisdiction can impact the competitive landscape for major customers.
This committee's authorization of the annual NDAA directly determines funding for defense contractors and R&D for military technologies, creating significant demand for Protolabs' rapid prototyping services.
This committee's jurisdiction covers aerospace, telecommunications, and tech sectors, which are major customers for Protolabs' custom parts, and regulates interstate commerce critical to its business model.